| 1 | [SID85148314] | Active | EC50 | 1.449 | Oxadiazole SAR compounds tested by Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 activated mutant [AID2009, Type: confirmatory] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Active | | EC50 | 1.449 [uM] | | BioAssay | Oxadiazole SAR compounds tested by Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 activated mutant | | AID | 2009 | | BioAssay type | confirmatory | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 2 | [SID87349202] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID87349202] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID87349202] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID87349202] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID87349202] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID87349202] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID85148314] | Active | | | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer [AID2393_3, Type: other] | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Active | | BioAssay | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer | | AID | 2393 | | BioAssay type | other | | Target | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] | | PubMed | | | Data Table |  |
|
| 9 | [SID85148314] | Active | | | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer [AID2393_4, Type: other] | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Active | | BioAssay | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer | | AID | 2393 | | BioAssay type | other | | Target | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] | | PubMed | | | Data Table |  |
|
| 10 | [SID85148314] | Active | | | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer [AID2393_6, Type: other] | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Active | | BioAssay | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer | | AID | 2393 | | BioAssay type | other | | Target | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] | | PubMed | | | Data Table |  |
|
| 11 | [SID85148314] | Active | | | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer [AID2393_2, Type: other] | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Active | | BioAssay | Dose Response of compounds for six proteins with constant GTP under the condition of Mg buffer | | AID | 2393 | | BioAssay type | other | | Target | Rho GTPase activating protein 1 [Homo sapiens] [gi:4757766] | | PubMed | | | Data Table |  |
|
| 12 | [SID87349202] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID87349202] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID85148314] | Inactive | EC50 | 0.305 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype [AID2031, Type: confirmatory] | GTP-binding protein (rab7) [Canis lupus familiaris] [gi:164058] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 0.305 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype | | AID | 2031 | | BioAssay type | confirmatory | | Target | GTP-binding protein (rab7) [Canis lupus familiaris] [gi:164058] | | PubMed | | | Data Table |  |
|
| 15 | [SID85148314] | Inactive | EC50 | 2.104 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant [AID2051, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 2.104 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant | | AID | 2051 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 16 | [SID85148314] | Inactive | EC50 | 2.104 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant [AID2051, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 2.104 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant | | AID | 2051 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 17 | [SID85148314] | Inactive | EC50 | 2.535 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype [AID2033, Type: confirmatory] | Ras-related protein Rab-2 [gi:46577642] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 2.535 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype | | AID | 2033 | | BioAssay type | confirmatory | | Target | Ras-related protein Rab-2 [gi:46577642] | | PubMed | | | Data Table |  |
|
| 18 | [SID87349202] | Inactive | Potency | 14.1254 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype [AID2037, Type: confirmatory] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype | | AID | 2037 | | BioAssay type | confirmatory | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 20 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype [AID2027, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype | | AID | 2027 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 21 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype [AID2027, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype | | AID | 2027 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 22 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2042, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2042 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 23 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2042, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2042 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 24 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2042, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2042 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 25 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2053, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2053 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 26 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2053, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2053 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 27 | [SID85148314] | Inactive | EC50 | 30 | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2053, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85148314 | | CID | 44143705 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Oxadiazole SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2053 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 28 | [SID87349202] | Inactive | Potency | 89.1251 | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 29 | [SID87349202] | Inactive | Potency | 89.1251 | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 30 | [SID87349202] | Inactive | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 31 | [SID87349202] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 32 | [SID87349202] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 33 | [SID87349202] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 34 | [SID87349202] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 35 | [SID87349202] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 36 | [SID87349202] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 37 | [SID87349202] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 38 | [SID87349202] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 39 | [SID87349202] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 40 | [SID87349202] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 41 | [SID87349202] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 42 | [SID87349202] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 43 | [SID87349202] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 44 | [SID87349202] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 45 | [SID87349202] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 46 | [SID87349202] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 47 | [SID87349202] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|
| 48 | [SID87349202] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 49 | [SID87349202] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 50 | [SID87349202] | Inactive | Potency | | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 87349202 | | CID | 44143705 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|